DNA vaccines against COVID-19: Perspectives and challenges
MM Silveira, GMSG Moreira, M Mendonça - Life sciences, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus known
as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is associated …
as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is associated …
DNA vaccines for SARS-CoV-2: toward third-generation vaccination era
ABSTRACT Introduction: Coronavirus outbreak 2019 (COVID-19) has affected all the
corners of the globe and created chaos to human life. In order to put some control on the …
corners of the globe and created chaos to human life. In order to put some control on the …
Nucleic acid vaccines for COVID-19: a paradigm shift in the vaccine development arena
Coronavirus disease, COVID-19, has touched every country globally except five countries
(North Korea, Turkmenistan, Tonga, Tuvalu and Nauru). Vaccination is the most effective …
(North Korea, Turkmenistan, Tonga, Tuvalu and Nauru). Vaccination is the most effective …
A brief review on DNA vaccines in the era of COVID-19
This article provides a brief overview of DNA vaccines. First, the basic DNA vaccine design
strategies are described, then specific issues related to the industrial production of DNA …
strategies are described, then specific issues related to the industrial production of DNA …
India's DNA Covid vaccine is a first—more are coming
S Mallapaty - Nature, 2021 - nature.com
Nature| Vol 597| 9 September 2021| 161© 2021 Springer Nature Li mited. All rights
reserved. 50 million doses by early next year. Several other DNA vaccines are being …
reserved. 50 million doses by early next year. Several other DNA vaccines are being …
Advances in gene-based vaccine platforms to address the COVID-19 pandemic
D Pushparajah, S Jimenez, S Wong, H Alattas… - Advanced drug delivery …, 2021 - Elsevier
The novel betacoronavirus, SARS-CoV-2 (severe acute respiratory syndrome coronavirus
2), has spread across the globe at an unprecedented rate since its first emergence in Wuhan …
2), has spread across the globe at an unprecedented rate since its first emergence in Wuhan …
COVID-19 vaccines: an overview of different platforms
D Kudlay, A Svistunov - Bioengineering, 2022 - mdpi.com
Vaccination is one of the key strategies to stop the COVID-19 pandemic. This review aims to
evaluate the current state of vaccine development and to determine the issues that merit …
evaluate the current state of vaccine development and to determine the issues that merit …
Advances in the design and development of SARS-CoV-2 vaccines
XL Peng, JSY Cheng, HL Gong, MD Yuan… - Military Medical …, 2021 - Springer
Since the end of 2019, coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. The RNA …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. The RNA …
COVID-19 vaccines: rapid development, implications, challenges and future prospects
S Kashte, A Gulbake, SF El-Amin III, A Gupta - Human cell, 2021 - Springer
COVID-19 has affected millions of people and put an unparalleled burden on healthcare
systems as well as economies throughout the world. Currently, there is no decisive therapy …
systems as well as economies throughout the world. Currently, there is no decisive therapy …
COVID-19 vaccine: where are we now and where should we go?
S Soleimanpour, A Yaghoubi - Expert review of vaccines, 2021 - Taylor & Francis
Introduction The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
currently caused the pandemic with a high progressive speed and has been considered as …
currently caused the pandemic with a high progressive speed and has been considered as …